Contract

Associate Manager

Contracts

Posted on 9/27/2025

Stryker

Stryker

10,001+ employees

Manufactures orthopedic and surgical medical devices

No salary listed

Hamilton, ON, Canada

Hybrid

Hybrid work flexibility indicates a mix of remote and in-office work.

Category
Consulting (1)
Required Skills
Power BI
SAP Products
Salesforce
Requirements
  • Bachelor’s degree in business administration, Finance or a related field required.
  • 6+ years of progressive experience in contracts, pricing, or commercial operations.
  • 2+ years of people leadership experience.
  • Experience with contracts, healthcare procurement, and rebate structures.
  • Strong financial acumen with the ability to assess risk and model financial impact.
  • Proven leadership experience managing cross-functional teams in contracts, pricing, or commercial operations.
  • Healthcare procurement
Responsibilities
  • Proactively collaborates with internal teams/departments to promote a culture of inclusiveness and cooperation.
  • Consistently meets service delivery expectations based on input from the business.
  • Responsible to live and exemplify Stryker’s Values: Integrity, Accountability, People, and Performance.
  • Build and nurture a high-performing team by actively coaching, mentoring, and providing necessary training to team members.
  • Conduct annual performance reviews and regular interim reviews, providing constructive feedback and setting clear, achievable goals.
  • Develop and implement strategies to maintain high levels of employee engagement, satisfaction, and retention.
  • Facilitate open and effective communication within the team, ensuring that all members are informed, motivated, and aligned with the organization’s goals and strategies.
  • Oversee and support the contract team by monitoring workload distribution, ensuring timely handling of requests, conducting quality checks, reviewing high-level contract terms and templates, and auditing processes and documents for compliance and accuracy.
  • Oversee the entire Commercial and ProCare contract lifecycle, including drafting, redlines, negotiation, execution, and renewal, while ensuring compliance with company guidelines and regulations, maintaining accurate documentation, and managing policies and processes for commercial contracts.
  • Collaborate with legal, commercial, and their contract team to align contracts with business objectives, mitigate financial implications and risks, and manage negotiations to ensure adherence to company policies and organizational goals.
  • Serve as the primary contract liaison for their assigned commercial group, acting as a trusted advisor.
  • Work closely with the Contracts Manager (O&S) ensuring a high degree of collaboration and alignment across MSNT & O&S, driving consistency in contract standards, and a unified approach to risk management.
  • Ensure timely and accurate processing of ProCare service agreements, amendments, and renewals in alignment with customer expectations and service delivery standards.
  • Build strong relationships with customers by actively engaging with them, understanding their unique needs and challenges, providing timely and effective solutions, and consistently delivering exceptional service and support.
  • Partner closely with our Proposals and Pricing teams to ensure contractual terms in RFPs are consistent with contractual term standards and pricing models are appropriately structured.
  • Responsible for maintaining and improving the Contract Lifecycle Management (CLM) system by designing, managing and refining documents, templates, workflows, and approval, automating steps, overseeing user management, and providing training and change management.
  • Actively seeks and shares best practices across the organization to identify process improvement and automation opportunities.
  • Develop and implement standard procedures, work instructions, and policies, while also assisting with internal and external audits and promoting industry best practices like Medtech Canada & WCC.
  • Develops and manages visualization and dashboarding solutions for the Contracts team, transforming data into actionable insights through reporting and performance metrics analysis, and presenting findings with recommendations that drive decision making and provoke action.
  • Key member on strategic initiatives including acquisition integrations, key projects impacting department (Power BI, Salesforce.com, Malbek, SAP etc.)
  • Other responsibilities as assigned by Senior Manager.
Desired Qualifications
  • Master's degree
  • Bilingual (French & English)
  • Possess robust proficiency in ERP, CLM, CRM, PowerBI, and Microsoft Office suite.
  • Knowledge of procurement at the hospital, regional, provincial, and national buying group levels to ensure alignment with customer and government-imposed terms & conditions as well as contract terminology, practices and concepts.

Stryker designs, manufactures, and sells medical devices across multiple areas, including surgical equipment, neurotechnology, and orthopedic implants, to hospitals and clinics worldwide. Its products are developed through engineering and clinical input, then manufactured and distributed to healthcare providers who use them during procedures to improve patient care and surgical efficiency. Stryker differentiates itself from competitors with a broad, integrated portfolio, a global sales and service network, and a strong emphasis on quality and ongoing product development to support safer, more efficient procedures. The company’s goal is to advance patient outcomes by delivering reliable, effective medical devices that expand access to care globally.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Simplify Jobs

Simplify's Take

What believers are saying

  • Robotic surgery leadership drives double-digit sales growth through 2025.
  • India Trident II launch targets aging population's rising hip surgeries.
  • Peripheral vascular expansion via IVL meets growing arterial disease demand.

What critics are saying

  • Handala cyberattack on March 11 delays ortho supply chain 3-6 months.
  • Zimmer Biomet Persona IQ erodes ortho share with real-time analytics.
  • J&J Velys captures 25% more knee procedures from Mako in 6-12 months.

What makes Stryker unique

  • Stryker holds 39.1% US market share in orthopedic product manufacturing.
  • Trident II Acetabular System integrates Mako SmartRobotics for hip replacements.
  • Amplitude Vascular Systems acquisition adds CO₂ IVL for peripheral arteries.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical & prescription plans

Supplemental health benefits

Flexible Spending accounts

Employee Assistance Program

Short-term & long-term disability

Tuition reimbursement

401(k) plan

Employee Stock Purchase Plan

Company News

ASC News
Apr 13th, 2026
ASC Technology Roundup: Distalmotion Files for Expanded Robotic Gynecology Clearance; Stryker, Medtronic Make Acquisitions

Distalmotion targets ASC gynecology programs with new FDA filing Distalmotion has submitted a 510(k) application to the FDA seeking to expand the label of its Dexter robotic surgery system into additional gynecological indications, the company announced April 1. The filing covers sacrocolpopexy, sacrocervicopexy and endometriosis resection. Sacrocolpopexy and sacrocervicopexy are procedures used to treat pelvic…

Market Wire News
Apr 13th, 2026
Stryker to acquire Amplitude Vascular Systems, adding next-gen IVL tech to peripheral vascular portfolio

Stryker Corporation has signed a definitive agreement to acquire Amplitude Vascular Systems, a Boston-based medical technology company developing next-generation intravascular lithotripsy technology for treating calcified peripheral arterial disease. Financial terms were not disclosed. AVS's technology uses pulsed CO₂-generated pressure waves delivered through a balloon catheter to fracture calcium deposits. The platform aims to enhance catheter deliverability, treatment speed and therapy efficiency. The acquisition will strengthen Stryker's peripheral vascular portfolio and expand its presence in arterial disease treatment. Stryker CEO Kevin Lobo said the deal advances the company's vision to build a comprehensive peripheral vascular platform addressing significant clinical needs. IVL technology is experiencing strong growth as physicians increasingly adopt it for calcium modification in complex cardiovascular procedures. The transaction remains subject to customary closing conditions.

Yahoo Finance
Mar 18th, 2026
Stryker posts 11% Q4 growth amid tariff pressures, margin expansion continues

Stryker has raised $120 million in a Series C round led by Ribbit Capital, valuing the medical technology company at $1.45 billion. The funding comes despite shares declining 7.6% over the past six months, outperforming the industry's 19.7% drop. The company delivered 11% organic sales growth in Q4 2025 and 10.3% for the full year, marking its fourth consecutive year of double-digit growth. Performance was broad-based across its Orthopaedics, MedSurg and Neurotechnology segments, driven by strong procedural volumes and favourable demographics. Stryker achieved over 100 basis points of operating margin expansion for the second consecutive year despite tariff pressures. The company enters 2026 with a robust capital equipment backlog, though rising interest costs and tariffs present near-term challenges. Analysts maintain a Hold rating on the stock.

Yahoo Finance
Mar 13th, 2026
Stryker shares fall 9% to $339 after Iranian cyberattack wipes 200,000+ systems

Stryker shares fell 9% to $339 following a destructive cyberattack by Iranian-linked group Handala that wiped over 200,000 systems and disrupted manufacturing and shipping operations across 56,000 employees in 61 countries. The medical technology company confirmed disruptions to order processing but stated there was no indication of ransomware. Unlike typical ransomware attacks, this wiper attack permanently deleted data rather than holding it for ransom, complicating recovery efforts. The incident threatens Stryker's 8% to 9.5% organic growth guidance for 2026 if operations fail to normalise quickly. Stryker generated $25 billion in revenue in 2025 with $4.283 billion in free cash flow and holds $4 billion in cash. Analysts maintain a consensus price target of $424.89 with 22 buy ratings and no sell ratings among 30 covering analysts.

Yahoo Finance
Mar 12th, 2026
Stryker reports 11.4% revenue growth in Q4, beating estimates with $7.17B

Stryker reported Q4 revenues of $7.17 billion, up 11.4% year-over-year and exceeding analyst expectations by 0.8%. The medical device manufacturer, which impacts over 150 million patients annually through its orthopaedics, surgical tools, neurotechnology and patient care solutions, delivered what CEO Kevin Lobo called "an outstanding finish to 2025". The company achieved double-digit sales and adjusted earnings per share growth for both the quarter and full year, whilst expanding adjusted operating margin by at least 100 basis points for the second consecutive year. Across the medical devices and supplies sector, the six diversified stocks tracked reported mixed Q4 results. As a group, revenues beat consensus estimates by 1.9%, though share prices have declined an average of 5.1% since the latest earnings announcements.

INACTIVE